Cingulate Achieves Key Manufacturing Milestone in the Development of Its Adhd Drug Ctx-1301 in Preparation for FDA Marketing Clearance
環線製藥在製備FDA營銷許可證過程中,在其ADHD藥物CTX-1301的製造方面實現了重要的里程碑。
Cingulate Achieves Key Manufacturing Milestone in the Development of Its Adhd Drug Ctx-1301 in Preparation for FDA Marketing Clearance
環線製藥在製備FDA營銷許可證過程中,在其ADHD藥物CTX-1301的製造方面實現了重要的里程碑。
譯文內容由第三人軟體翻譯。